Skip to main content
CGEM logo

CGEM · Cullinan Therapeutics, Inc.

$17.21 -0.27 (-1.52%)
Market Cap
$1.07B
Shares
61.46M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 176
Total Value: $930,398,445
Total Shares: 65,217,557
Showing 1–100 of 180 holdings by value · page 1 of 2

Institutional Ownership Trend

22 quarters

Holder Concentration

Across 173 13F filers
Top Holder
13.7%
Jun 2023 → Mar 2026 · range 11.6% – 20.7%
of institutional value
Top 5
45.9%
Jun 2023 → Mar 2026 · range 36.5% – 54.3%
of institutional value
Top 10
62.2%
Jun 2023 → Mar 2026 · range 53.1% – 72.2%
of institutional value
HHI
565
Jun 2023 → Mar 2026 · range 424 – 817
Broadly held
Showing 100 of 180
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1789972 CUSIP 230031106 13F (30d) 25 filings 25 filers Visit website Investor relations